title: Reply to: Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.
authors.affiliation: Clinic for Radiotherapy and Oncology, J.W. Goethe University Hospital, Frankfurt a. M., Germany. panagiotis.balermpas@kgu.de.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Balermpas
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy; D002945:Cisplatin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D010039:Otorhinolaryngologic Neoplasms / Q000628:therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002945:Cisplatin